Volume | 492,984 |
|
|||||
News | - | ||||||
Day High | 7.84 | Low High |
|||||
Day Low | 7.42 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CareDx Inc | CDNA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
7.62 | 7.42 | 7.84 | 7.55 | 7.56 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,296 | 492,984 | $ 7.63 | $ 3,762,157 | - | 4.80 - 12.93 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:40:24 | 20 | $ 7.56 | USD |
CareDx Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
390.93M | 51.78M | - | 280.32M | -190.28M | -3.68 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CareDx News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDNA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.01 | 8.7573 | 7.42 | 8.03 | 548,555 | -0.46 | -5.74% |
1 Month | 10.60 | 10.71 | 7.42 | 8.76 | 615,799 | -3.05 | -28.77% |
3 Months | 8.63 | 12.8337 | 7.42 | 9.72 | 788,095 | -1.08 | -12.51% |
6 Months | 4.92 | 12.93 | 4.80 | 9.44 | 1,046,292 | 2.63 | 53.46% |
1 Year | 8.14 | 12.93 | 4.80 | 9.01 | 940,265 | -0.59 | -7.25% |
3 Years | 79.58 | 96.88 | 4.80 | 23.45 | 897,562 | -72.03 | -90.51% |
5 Years | 26.30 | 99.83 | 4.80 | 28.81 | 826,477 | -18.75 | -71.29% |
CareDx Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. |